US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist

8.120
-0.050-0.61%

Close Mar 27 16:00 ET

8.120
0.0000.00%

Post 16:24 ET

784.63MMarket Cap-15.92P/E (TTM)

Avadel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avadel Pharmaceuticals Q4 2024 Earnings Date

Currency：USDMar 3, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	50.03M	50.41M	+376.67K
Beat Est.	+157.20%	+159.14%	+0.75%
EPS	-0.04	-0.05	-<0.01
Miss Est.	+85.17%	+82.76%	-16.28%

Analyst Rating

Strong Buy

Mar 27, 2025

Avadel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 58.062M	--
--	2025/Q1	-- / 50.500M	--
Mar 3, 2025	2024/Q4	50.410M / 50.033M	--
Nov 12, 2024	2024/Q3	50.025M / 48.629M	--
Aug 8, 2024	2024/Q2	41.504M / 37.579M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 58.062M--

--2025/Q1-- / 50.500M--

Mar 3, 20252024/Q450.410M / 50.033M--

Nov 12, 20242024/Q350.025M / 48.629M--

Aug 8, 20242024/Q241.504M / 37.579M--

Unlock Free Earnings Estimates

Open Account

Avadel Pharmaceuticals Earnings Reports

Avadel Pharmaceuticals | 10-K: FY2024 Annual Report

Mar 3 22:17

Avadel Pharmaceuticals | 8-K: Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3 20:10

Avadel Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 22:39

Avadel Pharmaceuticals | 8-K: Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Nov 12, 2024 22:30